Literature DB >> 11909739

Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis.

J Brian de Souza1, Eleanor M Riley.   

Abstract

Cerebral malaria is a serious and often fatal complication of Plasmodium falciparum infections. The precise mechanisms involved in the onset of neuropathology remain unknown, but parasite sequestration in the brain, metabolic disturbances and host immune responses are all thought to be involved. This review outlines the current state of knowledge of cerebral disease in humans, and discusses the contribution of studies of animal models to elucidation of the underlying mechanisms.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11909739     DOI： 10.1016/s1286-4579(02)01541-1

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  77 in total

Review 1.  Cytokines in the pathogenesis of and protection against malaria.

Authors:  Iñigo Angulo; Manuel Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 2.  In vivo imaging of infection immunology--4I's!

Authors:  Paul Garside; James Brewer
Journal:  Semin Immunopathol       Date:  2010-07-07       Impact factor: 9.623

3.  Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria.

Authors:  Fiona E Lovegrove; Sina A Gharib; Samir N Patel; Cheryl A Hawkes; Kevin C Kain; W Conrad Liles
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

4.  Isolation and analysis of brain-sequestered leukocytes from Plasmodium berghei ANKA-infected mice.

Authors:  Victoria Ryg-Cornejo; Lisa J Ioannidis; Diana S Hansen
Journal:  J Vis Exp       Date:  2013-01-02       Impact factor: 1.355

5.  Role of the aryl hydrocarbon receptor in the immune response profile and development of pathology during Plasmodium berghei Anka infection.

Authors:  Fatima Brant; Aline S Miranda; Lisia Esper; David Henrique Rodrigues; Lucas Miranda Kangussu; Daniella Bonaventura; Frederico Marianetti Soriani; Vanessa Pinho; Danielle G Souza; Milene Alvarenga Rachid; Louis M Weiss; Herbert B Tanowitz; Mauro Martins Teixeira; Antônio Lucio Teixeira; Fabiana Simão Machado
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

6.  FTIR imaging of brain tissue reveals crystalline creatine deposits are an ex vivo marker of localized ischemia during murine cerebral malaria: general implications for disease neurochemistry.

Authors:  Mark J Hackett; Joonsup Lee; Fatima El-Assaad; James A McQuillan; Elizabeth A Carter; Georges E Grau; Nicholas H Hunt; Peter A Lay
Journal:  ACS Chem Neurosci       Date:  2012-09-11       Impact factor: 4.418

7.  Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria.

Authors:  Roberta Spaccapelo; Chris J Janse; Sara Caterbi; Blandine Franke-Fayard; J Alfredo Bonilla; Luke M Syphard; Manlio Di Cristina; Tania Dottorini; Andrea Savarino; Antonio Cassone; Francesco Bistoni; Andrew P Waters; John B Dame; Andrea Crisanti
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

8.  The specific, reversible JNK inhibitor SP600125 improves survivability and attenuates neuronal cell death in experimental cerebral malaria (ECM).

Authors:  Sripada Santosh Anand; Mulaka Maruthi; Phanithi Prakash Babu
Journal:  Parasitol Res       Date:  2013-02-28       Impact factor: 2.289

9.  Algorithms to predict cerebral malaria in murine models using the SHIRPA protocol.

Authors:  Yuri C Martins; Guilherme L Werneck; Leonardo J Carvalho; Beatriz P T Silva; Bruno G Andrade; Tadeu M Souza; Diogo O Souza; Cláudio T Daniel-Ribeiro
Journal:  Malar J       Date:  2010-03-24       Impact factor: 2.979

Review 10.  Natural regulatory T cells in malaria: host or parasite allies?

Authors:  Diana S Hansen; Louis Schofield
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.